SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Company

Acumen Pharmaceuticals, Inc.

Filed

February 15, 2022

Accession Number

0001387131-22-001971

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →